Can a cyclooxygenase inhibitor be an option for treatment of ovarian hyperstimulation syndrome?
Hasan Çilgin Medicine Faculty, Obstetrics and Gynecology Department, Kafkas University, Kars, Turkey Purpose: This study aimed to investigate the role of a cyclooxygenase inhibitor in ovarian hyperstimulation syndrome (OHSS) treatment and compare it with cabergoline.Materials and method...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-04-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/can-a-cyclooxygenase-inhibitor-be-an-option-for-treatment-of-ovarian-h-peer-reviewed-article-DDDT |